<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:department>Sch of Biosciences</gtr:department><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/818CD6C9-61EE-41F2-9F37-0C7A8F43E25D"><gtr:id>818CD6C9-61EE-41F2-9F37-0C7A8F43E25D</gtr:id><gtr:name>University of Birmingham</gtr:name><gtr:address><gtr:line1>Edgbaston Park Road</gtr:line1><gtr:line2>Edgbaston</gtr:line2><gtr:postCode>B15 2TT</gtr:postCode><gtr:region>West Midlands</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/7008F77D-D7F3-4558-AEE7-9195B7890A2D"><gtr:id>7008F77D-D7F3-4558-AEE7-9195B7890A2D</gtr:id><gtr:name>Moorfields Eye Hospital NHS Foundation Trust</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/95CDF33E-9090-49AA-A8BC-BE26B2F7E4C3"><gtr:id>95CDF33E-9090-49AA-A8BC-BE26B2F7E4C3</gtr:id><gtr:firstName>Alistair</gtr:firstName><gtr:otherNames>Keith</gtr:otherNames><gtr:surname>Denniston</gtr:surname><gtr:roles><gtr:role><gtr:name>FELLOW</gtr:name></gtr:role><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0600416"><gtr:id>D49619EC-14BB-410B-9BA0-9943045D28D0</gtr:id><gtr:title>Regulation of dendritic cell function by the ocular microenvironment in uveitis</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Fellowship</gtr:grantCategory><gtr:grantReference>G0600416</gtr:grantReference><gtr:abstractText>The immune system protects the individual from a large range of infections. Although the immune response is highly efficient, this can result in some damage to surrounding areas. For the majority of organs this does not present a problem. However, in certain organs any significant immune mediated damage could threaten the survival of the individual. For these organs the immune response is carefully controlled and they are described as having immune privilege. The eye is a well studied example of an organ with immune privilege. It is clear that when inflammation occurs in the eye (uveitis) this contradicts the immune privileged status, with some patients suffering severe sight-threatening disease. The aim of our research is to identify the way in which the immune response is altered in uveitis. We wish to study the changes that occur in a specific immune cell, the dendritic cell, which acts as a co-ordinator of immune responses. By identifying the changes that occur in these cells in patients with uveitis we aim to identify new therapeutic options for this potentially blinding disease.</gtr:abstractText><gtr:technicalSummary>Uveitis (intraocular inflammation) is a group of diseases characterised by inflammation of the uveal tract. Although many cases resolve rapidly, a number will develop persistent severe sight-threatening inflammation. There is clear evidence that activated T cells are involved in the pathogenesis of uveitis (intraocular inflammation) in both humans and animal models of the disease. This suggests that mature dendritic cells (DC) are generated within the inflamed ocular microenvironment, in contrast to the immunosuppressive conditions reported to maintain immune privilege in this tissue. We propose to determine whether the ocular microenvironment (aqueous humour; AqH) in uveitis can deviate DC towards a pro-inflammatory phenotype. We will determine whether the resting non-inflammatory ocular environment (AqH) induces regulatory DC, and if this can be overcome by additional inflammatory/pathogen-derived signals. This will be compared to the capacity of AqH to regulate DC function altered during episodes of uveitis. In addition, we will use AqH from patients receiving glucocorticoid treatment at the time of sampling, allowing us to study the effects of this treatment on DC function. DC will be generated from peripheral blood monocytes by culture with IL-4 and GM-CSF. AqH will be added to immature DC alone and in combination with a number of pro-inflammatory stimuli (cytokines, Toll-like receptor ligands). The phenotype of the resulting DC will be studied, in particular the expression of a number of molecules involved in the stimulation of T cells and the secretion of key cytokines. DC will be cultured with CD4+ allogeneic T cells to determine their ability to stimulate T cell proliferation and effector function. We ultimately aim to identify the signals that regulate changes in DC maturation, and consequently the activation of T cells in uveitis, ultimately providing new therapeutic targets for this group of diseases.</gtr:technicalSummary><gtr:fund><gtr:end>2009-10-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2006-11-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>196483</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Moorfields Eye Hospital NHS Foundation Trust</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Retinal Imaging</gtr:department><gtr:description>Imaging in Uveitis Partnership</gtr:description><gtr:id>BE3FD349-4EFF-4679-8BAC-A16467510B6A</gtr:id><gtr:impact>Keane PA, Allie M, Turne SJ, Southwort HS, Sadda SR, Murray PI, Denniston AK.Characterization of Birdshot Chorioretinopathy using Extramacular Enhanced Depth Optical Coherence Tomography. JAMA Ophthalmol 2012 (EPub ahead of print)</gtr:impact><gtr:outcomeId>bMt8yB4VEZV-2</gtr:outcomeId><gtr:partnerContribution>Data analysis and technical design</gtr:partnerContribution><gtr:piContribution>Design of studies</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Education Video on the Eye Clinic</gtr:description><gtr:form>A broadcast e.g. TV/radio/film/podcast (other than news/press)</gtr:form><gtr:geographicReach>Regional</gtr:geographicReach><gtr:id>EF8300FC-E596-4E15-BFB5-00F0AE280265</gtr:id><gtr:impact>Educational video on the embedding of ophthalmic examination within the multidisciplinary clinic for rare diseases</gtr:impact><gtr:outcomeId>58bee9abd555b1.69427216</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/politicians</gtr:primaryAudience><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>'A Sight for Sore Eyes' Exhibition at the British Science Festival</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:id>BB3CA6C2-E76C-428C-8112-BB9094CF113D</gtr:id><gtr:impact>A half-day series of talks covering Ocular Infection and Immunity and how our research impacts on this; audience 20-30 of public, some of whom had ocular disease. Also we put on an interactive exhibit run by 'Sherlock Holmes' where the public could diagnose ocular infections for themselves and work out the culprit organism. This was targeted at secondary school children upwards and ran over three days as part of The Body in Health and Disease exhibition at the BSF. The stand had a 'footfall' of around 1000 people.

Up to 45mins of questions at the end of the talks series. Many people attending the exhibit took literature away, and expressed that they had 'really learnt something'.</gtr:impact><gtr:outcomeId>NoEJqCp1gPh</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2010</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Birdshot Uveitis Society Day 2012</gtr:description><gtr:form>A talk or presentation</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>087AD281-A875-40D5-A153-88080B1E0380</gtr:id><gtr:impact>Presentation to 200 patients and their supporters;
Youtube video of the talk;

Ongoing involvement with the group</gtr:impact><gtr:outcomeId>iUPJ9FVKHzF</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Keynote/Invited Speaker</gtr:presentationType><gtr:primaryAudience>Participants in your research and patient groups</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Max Perutz Prize 2009 (Runner-up)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>AB0F5A25-643F-45A3-91E5-B9A833BDCC32</gtr:id><gtr:impact>Summary of research for lay audience

Published in the On-line Guardian</gtr:impact><gtr:outcomeId>01593FAB3E8</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2009</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>The Big Bang</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>24629B56-BE48-475A-B288-731BB0991C1E</gtr:id><gtr:impact>http://www.thebigbangfair.co.uk/home.cfm
From 15 - 17 March 2012, the Big Bang welcomed over 56,000 visitors to The NEC, Birmingham and &amp;quot;amazed them at just how exciting engineering and science can be&amp;quot;. Our stand provided visitors with the oportunity to try out corneal surgery on a tomato and showed videos of real ophthalmic surgery. There was a constant stream of visitors, with numerous questions about what we do.

Opportunities to present both our research and the translational outcome of what we do.</gtr:impact><gtr:outcomeId>RsbCBRLjFPZ</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>MRC Max Perutz Prize 2008 (Short-list)</gtr:description><gtr:form>A magazine, newsletter or online publication</gtr:form><gtr:id>93C0821B-7C0A-423E-A215-E3477F6BB6BA</gtr:id><gtr:impact>Summary of personal research for lay audience

Short-listed for prize; published as a podcast on the MRC website</gtr:impact><gtr:outcomeId>63A0EF2FB61</gtr:outcomeId><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:year>2008</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>14800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Fight for Sight/Olivia's Vision Small Grant</gtr:description><gtr:end>2013-10-02</gtr:end><gtr:fundingOrg>Fight for Sight</gtr:fundingOrg><gtr:id>564C0112-3B96-44DD-B3B4-66B7049ED7AA</gtr:id><gtr:outcomeId>Pbmc14V412P</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2012-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>800</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>British Society of Immunology Travel Award</gtr:description><gtr:end>2009-06-02</gtr:end><gtr:fundingOrg>British Society For Immunology</gtr:fundingOrg><gtr:id>CD7A991C-A7DF-4610-B9F5-7878B4379972</gtr:id><gtr:outcomeId>FF97243C3BA0</gtr:outcomeId><gtr:sector>Learned Society</gtr:sector><gtr:start>2009-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>700</gtr:amountPounds><gtr:country>United States of America</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>ARVO International Travel Grant</gtr:description><gtr:end>2008-06-02</gtr:end><gtr:fundingOrg>Association for Research in Vision and Ophthalmology (ARVO)</gtr:fundingOrg><gtr:id>B8880321-3F4F-45BE-95E9-1C4837A67B59</gtr:id><gtr:outcomeId>BF30C0584F70</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2008-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>219000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Equipment Funding</gtr:description><gtr:fundingOrg>Queen Elizabeth Hospital Birmingham Charity (QEHB)</gtr:fundingOrg><gtr:id>A5FBC80C-CA52-4ABB-AA8F-C4A527593B50</gtr:id><gtr:outcomeId>VcmyjYdpPHt</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>560000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Wellcome Trust Health Innovation Challenge</gtr:description><gtr:end>2019-05-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:id>B18BF32B-146D-439B-8482-2B04E99EEDAD</gtr:id><gtr:outcomeId>56de93108f7db5.87056025</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-05-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>28000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>AMS Wellcome Clinical Lecturer Starter Grant</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Academy of Medical Sciences (AMS)</gtr:fundingOrg><gtr:id>FCB43B4C-51C8-4907-BD6E-63C46E79BE9B</gtr:id><gtr:outcomeId>Xxj3m4pyJi50</gtr:outcomeId><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Benchside Spectrum of Translational Research in Ophthalmology</gtr:description><gtr:geographicReach>UK</gtr:geographicReach><gtr:id>F5CBCE82-2EF2-4BEF-9590-55A1AF04FA84</gtr:id><gtr:impact>Invited talk to a Royal College of Ophthalmologists Symposium to present the value of our studies based on sampling ocular fluids as a means of investigating pathogenesis and providing biomarkers to patietns with ophthalmic disease.</gtr:impact><gtr:outcomeId>e2K9RNkUJL9</gtr:outcomeId><gtr:type>Influenced training of practitioners or researchers</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs/><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>9AC7292B-8C28-41AE-BF91-B8EFAAEB6946</gtr:id><gtr:title>Cataract surgery in uveitis: a multicentre database study.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/223de347f407a52493f71e53c17bc658"><gtr:id>223de347f407a52493f71e53c17bc658</gtr:id><gtr:otherNames>Chu CJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>58bee78c66df87.72663117</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF4FB2F7-7747-42A7-A02F-44A02B12323D</gtr:id><gtr:title>Automated Analysis of Vitreous Inflammation Using Spectral-Domain Optical Coherence Tomography.</gtr:title><gtr:parentPublicationTitle>Translational vision science &amp; technology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ee51e111f02eb7aec99b2023ec7529d"><gtr:id>4ee51e111f02eb7aec99b2023ec7529d</gtr:id><gtr:otherNames>Keane PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2164-2591</gtr:issn><gtr:outcomeId>58bee78e3c6851.39252169</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8D7D396A-8C35-400C-B9AD-40CE492CC682</gtr:id><gtr:title>Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b8b363cc9ec32df933b95133cb9eb68"><gtr:id>6b8b363cc9ec32df933b95133cb9eb68</gtr:id><gtr:otherNames>Minos E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>58bee78e129d23.87812078</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>A6B9244C-CA5E-4124-913D-9DA1A67426F7</gtr:id><gtr:title>Quantitative analysis of vitreous inflammation using optical coherence tomography in patients receiving sub-Tenon's triamcinolone acetonide for uveitic cystoid macular oedema.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1863fb10577167fa3ec557af338d63e"><gtr:id>d1863fb10577167fa3ec557af338d63e</gtr:id><gtr:otherNames>Sreekantam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>58bee78bec6103.20908179</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8239598F-7285-4BE8-B9E9-8836430433C8</gtr:id><gtr:title>VISUALising a new framework for the treatment of uveitis.</gtr:title><gtr:parentPublicationTitle>Lancet (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0140-6736</gtr:issn><gtr:outcomeId>58bee700d64c60.26791244</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>10DD6041-7625-4AC0-9042-2A3C453A139A</gtr:id><gtr:title>Bilateral retinal vasculitis in a patient with systemic lupus erythematosus and its remission with rituximab therapy.</gtr:title><gtr:parentPublicationTitle>Lupus</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d9a86c55058bdbf6c22077c33ad74710"><gtr:id>d9a86c55058bdbf6c22077c33ad74710</gtr:id><gtr:otherNames>Hickman RA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0961-2033</gtr:issn><gtr:outcomeId>A41FF748466</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0054AB01-0128-433F-A161-BB0958916AD2</gtr:id><gtr:title>Systemic lupus erythematosus: An update for ophthalmologists.</gtr:title><gtr:parentPublicationTitle>Survey of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d2751f22ee49963135e104928948ec43"><gtr:id>d2751f22ee49963135e104928948ec43</gtr:id><gtr:otherNames>Papagiannuli E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0039-6257</gtr:issn><gtr:outcomeId>58bee78d6a1612.01753036</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>59032598-0825-4B04-A106-F2CCCB50F32B</gtr:id><gtr:title>Rheumatoid corneal melt: autoimmunity or infection?</gtr:title><gtr:parentPublicationTitle>JRSM short reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3c7a070d43ba16349c5d9a617184ca"><gtr:id>8d3c7a070d43ba16349c5d9a617184ca</gtr:id><gtr:otherNames>Williams GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>2042-5333</gtr:issn><gtr:outcomeId>pm_16202_22_21286224</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B5A115FF-784B-4EDC-972A-9A3F86E37162</gtr:id><gtr:title>Evaluation of Objective Vitritis Grading Method Using Optical Coherence Tomography: Influence of Phakic Status and Previous Vitrectomy.</gtr:title><gtr:parentPublicationTitle>American journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5c6c41d23dfa97d6322ce43b4a5fec59"><gtr:id>5c6c41d23dfa97d6322ce43b4a5fec59</gtr:id><gtr:otherNames>Zarranz-Ventura J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0002-9394</gtr:issn><gtr:outcomeId>58bee78e93aa17.99506545</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ADFE198F-C129-4C9F-987A-C8B22D644197</gtr:id><gtr:title>Adjunctive use of systematic retinal thickness map analysis to monitor disease activity in punctate inner choroidopathy.</gtr:title><gtr:parentPublicationTitle>Journal of ophthalmic inflammation and infection</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/97d4fea61d48abc093c09072c01d53e0"><gtr:id>97d4fea61d48abc093c09072c01d53e0</gtr:id><gtr:otherNames>Madhusudhan S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1869-5760</gtr:issn><gtr:outcomeId>58bee78d138d28.89808740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>15720EE6-8F2E-4869-9401-90A2C212F585</gtr:id><gtr:title>Aspirin as adjunctive treatment for giant cell arteritis.</gtr:title><gtr:parentPublicationTitle>The Cochrane database of systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d54e7f2e129804e49adb169604bf9392"><gtr:id>d54e7f2e129804e49adb169604bf9392</gtr:id><gtr:otherNames>Mollan SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>1361-6137</gtr:issn><gtr:outcomeId>545b3261c11751.75386087</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>782A57D5-FFCF-43D7-8C0A-8F074ED0E37E</gtr:id><gtr:title>The UK Diabetic Retinopathy Electronic Medical Record (UK DR EMR) Users Group, Report 2: real-world data for the impact of cataract surgery on diabetic macular oedema.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>5aa6e12b4566e8.99571876</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>16A9FE3B-800D-4C9F-A119-9809C537BBA9</gtr:id><gtr:title>Systemic Lupus Erythematosus</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9290ffb09023aa3da456a27f7e7df4e7"><gtr:id>9290ffb09023aa3da456a27f7e7df4e7</gtr:id><gtr:otherNames>Denniston A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:outcomeId>5aa6e12c7f7c31.71980322</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>625D5E01-38EA-49D1-86DF-C4B1BF5ED7E4</gtr:id><gtr:title>Ocular manifestations of systemic lupus erythematosus.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0def0a967b20e567a87cd96e5b112260"><gtr:id>0def0a967b20e567a87cd96e5b112260</gtr:id><gtr:otherNames>Sivaraj RR</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>7068596A722</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DE18EF3B-A12E-4682-80A6-F06C366678FA</gtr:id><gtr:title>Aqueous humor suppression of dendritic cell function helps maintain immune regulation in the eye during human uveitis.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>pm_16202_22_22247464</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>03B69DE3-DD9A-4316-A0DF-3AC59D5BE4CA</gtr:id><gtr:title>Controversies in the Pharmacological Treatment of Uveitis.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2a80691aa2b2db91bd9bcd10441012e"><gtr:id>b2a80691aa2b2db91bd9bcd10441012e</gtr:id><gtr:otherNames>Barry RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>58bee78ecbc067.79568356</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4F844CA-C799-436B-A122-A68F1739A405</gtr:id><gtr:title>The effectiveness of pharmacological agents for the treatment of uveitic macular oedema (UMO): a systematic review protocol.</gtr:title><gtr:parentPublicationTitle>Systematic reviews</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5e8203bdd65772f382d0f8880bd83c97"><gtr:id>5e8203bdd65772f382d0f8880bd83c97</gtr:id><gtr:otherNames>Tallouzi MO</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2046-4053</gtr:issn><gtr:outcomeId>58bee78d3b1a97.10595711</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6A268799-CAEC-4E3D-BBBE-C368E9555D3E</gtr:id><gtr:title>Research into Glaucoma and Ethnicity (ReGAE) 8: is there a relationship between social deprivation and acute primary angle closure?</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e5a69095ee3aa2d06c64e21a8a9967d0"><gtr:id>e5a69095ee3aa2d06c64e21a8a9967d0</gtr:id><gtr:otherNames>Nessim M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>3F530C922CF</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>AA094DC0-E6E7-4F78-9A47-580532B09722</gtr:id><gtr:title>Patent foramen ovale presenting as visual loss.</gtr:title><gtr:parentPublicationTitle>JRSM open</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/42f7c7c6107a6cd7198876022cb295cf"><gtr:id>42f7c7c6107a6cd7198876022cb295cf</gtr:id><gtr:otherNames>Liu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>2054-2704</gtr:issn><gtr:outcomeId>58bee78b849299.26949555</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>95B3C2C5-880B-4744-A50C-8E2B523FD390</gtr:id><gtr:title>Soluble gp130, an antagonist of IL-6 transsignaling, is elevated in uveitis aqueous humor.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/32913e75b4bffe5ee8a831a6dae920a3"><gtr:id>32913e75b4bffe5ee8a831a6dae920a3</gtr:id><gtr:otherNames>Simon D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2008-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>16554BAEE80</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>89264F8D-8A14-4C5D-A677-187AD01B8012</gtr:id><gtr:title>The Ocular Glymphatic System and Idiopathic Intracranial Hypertension: Author Response to &amp;quot;Hypodense Holes and the Ocular Glymphatic System&amp;quot;.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58bee700a293d6.83909695</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4290178-BB1E-4F6E-89CA-94E19C4D6F7D</gtr:id><gtr:title>The United Kingdom Diabetic Retinopathy Electronic Medical Record Users Group, Report 1: baseline characteristics and visual acuity outcomes in eyes treated with intravitreal injections of ranibizumab for diabetic macular oedema.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/750bfefddb5218433177902a554e50d9"><gtr:id>750bfefddb5218433177902a554e50d9</gtr:id><gtr:otherNames>Egan C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>58bee78ca63ee8.91360855</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F92D3C41-2EA3-4498-89A9-612A5432ABFF</gtr:id><gtr:title>Childhood blepharokeratoconjunctivitis: characterising a severe phenotype in white adolescents.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/713288566bbf578eb02be841a2703d8b"><gtr:id>713288566bbf578eb02be841a2703d8b</gtr:id><gtr:otherNames>Hamada S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>pm_16202_22_22504838</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0A1F76DE-18C0-4104-A635-F241C700EFC9</gtr:id><gtr:title>Systemic Lupus Erythematosus</gtr:title><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9290ffb09023aa3da456a27f7e7df4e7"><gtr:id>9290ffb09023aa3da456a27f7e7df4e7</gtr:id><gtr:otherNames>Denniston A</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:isbn>978-0-32-304434-9</gtr:isbn><gtr:outcomeId>56de925f2a5b06.53069618</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91A0B9FD-C722-41E8-8362-1472E487E641</gtr:id><gtr:title>Endogenous cortisol and TGF-beta in human aqueous humor contribute to ocular immune privilege by regulating dendritic cell function.</gtr:title><gtr:parentPublicationTitle>Journal of immunology (Baltimore, Md. : 1950)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0022-1767</gtr:issn><gtr:outcomeId>nZoLorHapZs</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CF23A913-5093-491F-9092-761C053D1117</gtr:id><gtr:title>Birdshot chorioretinopathy: current knowledge and new concepts in pathophysiology, diagnosis, monitoring and treatment.</gtr:title><gtr:parentPublicationTitle>Orphanet journal of rare diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/6b8b363cc9ec32df933b95133cb9eb68"><gtr:id>6b8b363cc9ec32df933b95133cb9eb68</gtr:id><gtr:otherNames>Minos E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1750-1172</gtr:issn><gtr:outcomeId>56e1316bc4c236.63640418</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>6FDA1444-7390-4189-A684-3EDDFEBA582B</gtr:id><gtr:title>Safety profile of anterior chamber paracentesis performed at the slit lamp.</gtr:title><gtr:parentPublicationTitle>Clinical &amp; experimental ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9604b2bafe20ba0ae429cf3671ac8982"><gtr:id>9604b2bafe20ba0ae429cf3671ac8982</gtr:id><gtr:otherNames>Trivedi D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1442-6404</gtr:issn><gtr:outcomeId>pm_16202_22_22050560</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB512235-840D-47C8-AC9F-23E0490D5169</gtr:id><gtr:title>Distinct types of fibrocyte can differentiate from mononuclear cells in the presence and absence of serum.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/dcb80ca8dcfba46d9f6a700959641e42"><gtr:id>dcb80ca8dcfba46d9f6a700959641e42</gtr:id><gtr:otherNames>Curnow SJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>523C11764B2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>772A53C1-6784-4238-95BE-7D960621CE7B</gtr:id><gtr:title>The use of transdermal optical coherence tomography to image the superficial temporal arteries.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d54e7f2e129804e49adb169604bf9392"><gtr:id>d54e7f2e129804e49adb169604bf9392</gtr:id><gtr:otherNames>Mollan SP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>58bee78cd9c6b7.13408606</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>DB2090AD-C7CB-4BDF-8510-F2E1390EC359</gtr:id><gtr:title>Increased CD1c+ mDC1 with mature phenotype regulated by TNFa-p38 MAPK in autoimmune ocular inflammatory disease.</gtr:title><gtr:parentPublicationTitle>Clinical immunology (Orlando, Fla.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0b9f563201ed3d1bb545f7fd9f4a7a34"><gtr:id>0b9f563201ed3d1bb545f7fd9f4a7a34</gtr:id><gtr:otherNames>Chen P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1521-6616</gtr:issn><gtr:outcomeId>5514845e1130b9.06687663</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>69AB2B63-04C5-4FEE-8B8E-93F6FB224946</gtr:id><gtr:title>Visualizing the Choriocapillaris Under Drusen: Comparing 1050-nm Swept-Source Versus 840-nm Spectral-Domain Optical Coherence Tomography Angiography.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa9b360d10099bbc9e1acdd7798f4d8f"><gtr:id>fa9b360d10099bbc9e1acdd7798f4d8f</gtr:id><gtr:otherNames>Lane M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58bee78c267033.55418720</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>299CBA69-F14D-4324-8F4F-9A3C67A972A6</gtr:id><gtr:title>The dominant human conjunctival epithelial CD8a?+ T cell population is maintained with age but the number of CD4+ T cells increases.</gtr:title><gtr:parentPublicationTitle>Age (Dordrecht, Netherlands)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3c7a070d43ba16349c5d9a617184ca"><gtr:id>8d3c7a070d43ba16349c5d9a617184ca</gtr:id><gtr:otherNames>Williams GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0161-9152</gtr:issn><gtr:outcomeId>pm_16202_22_21948184</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B8D64B7D-6EC1-41B1-BACA-A2D17C374052</gtr:id><gtr:title>Hydroxychloroquine-related retinal toxicity.</gtr:title><gtr:parentPublicationTitle>Rheumatology (Oxford, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/e45ddea8ca9182fb2a33d3606d24d2a3"><gtr:id>e45ddea8ca9182fb2a33d3606d24d2a3</gtr:id><gtr:otherNames>Ding HJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1462-0324</gtr:issn><gtr:outcomeId>58bee78ddde8d6.02065833</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>88F682C2-AFA5-48A2-9CDE-7F5AA506B6BE</gtr:id><gtr:title>Diagnostic and therapeutic challenges.</gtr:title><gtr:parentPublicationTitle>Retina (Philadelphia, Pa.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4ee51e111f02eb7aec99b2023ec7529d"><gtr:id>4ee51e111f02eb7aec99b2023ec7529d</gtr:id><gtr:otherNames>Keane PA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0275-004X</gtr:issn><gtr:outcomeId>pm_16202_22_22203336</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>39F6CFE7-89A4-49A1-ABF1-7444B4FB9D9A</gtr:id><gtr:title>Is ethnicity a risk factor for severe retinopathy of prematurity?</gtr:title><gtr:parentPublicationTitle>Archives of disease in childhood. Fetal and neonatal edition</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c4cff86530c914124b6565de85c5bd9f"><gtr:id>c4cff86530c914124b6565de85c5bd9f</gtr:id><gtr:otherNames>Aralikatti AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1359-2998</gtr:issn><gtr:outcomeId>ECF9520B42E</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>9E1A7462-02C7-4E98-94FA-6290326F8290</gtr:id><gtr:title>Phacoemulsification and foldable intraocular lens implantation combined with 23-gauge transconjunctival sutureless vitrectomy.</gtr:title><gtr:parentPublicationTitle>Journal of cataract and refractive surgery</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/cdded6c1bb08b2197dd6475e40356e0b"><gtr:id>cdded6c1bb08b2197dd6475e40356e0b</gtr:id><gtr:otherNames>Sood V</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0886-3350</gtr:issn><gtr:outcomeId>8524EFF7F4A</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4EEBC09-A790-4044-92A5-22939A588EFD</gtr:id><gtr:title>Conjunctival Neutrophils Predict Progressive Scarring in Ocular Mucous Membrane Pemphigoid.</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/8d3c7a070d43ba16349c5d9a617184ca"><gtr:id>8d3c7a070d43ba16349c5d9a617184ca</gtr:id><gtr:otherNames>Williams GP</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58bee78ba8c1a3.48354911</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>96D43C57-BBE5-48FC-A810-09E7EDD78526</gtr:id><gtr:title>Drug discovery in ophthalmology: past success, present challenges, and future opportunities.</gtr:title><gtr:parentPublicationTitle>BMC ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/c1baf844c9111d89a423a00a2de2bb69"><gtr:id>c1baf844c9111d89a423a00a2de2bb69</gtr:id><gtr:otherNames>Gower NJD</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>1471-2415</gtr:issn><gtr:outcomeId>58bee78e6d6a29.75954469</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>313C320C-F5B7-4119-8607-88ADDA47A4AE</gtr:id><gtr:title>Reply to wertheim et al. The minim technique for diagnostic anterior chamber paracentesis.</gtr:title><gtr:parentPublicationTitle>Eye (London, England)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b76e73a3be6ceb36931bc0c47aebbe20"><gtr:id>b76e73a3be6ceb36931bc0c47aebbe20</gtr:id><gtr:otherNames>Amissah-Arthur KN</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0950-222X</gtr:issn><gtr:outcomeId>3CE2CE526D2</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B154B846-D849-47B5-AE2E-4E36F2012F8F</gtr:id><gtr:title>Previous Intravitreal Therapy Is Associated with Increased Risk of Posterior Capsule Rupture during Cataract Surgery.</gtr:title><gtr:parentPublicationTitle>Ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f881700f61dc588e3fb2adbf3cb9b1f9"><gtr:id>f881700f61dc588e3fb2adbf3cb9b1f9</gtr:id><gtr:otherNames>Lee AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0161-6420</gtr:issn><gtr:outcomeId>58bee78da0dea1.11135203</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>BD4BFD7F-383C-446D-868A-788F41E636B4</gtr:id><gtr:title>Survey of expert practice and perceptions of the supporting clinical evidence for the management of uveitis-related cataract and cystoid macular oedema.</gtr:title><gtr:parentPublicationTitle>Ocular immunology and inflammation</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d1863fb10577167fa3ec557af338d63e"><gtr:id>d1863fb10577167fa3ec557af338d63e</gtr:id><gtr:otherNames>Sreekantam S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0927-3948</gtr:issn><gtr:outcomeId>pm_16202_22_21823935</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>D5C7777A-DA1E-47D2-8AE3-8B3C4271600D</gtr:id><gtr:title>Multiple deprivation, vision loss, and ophthalmic disease in adults: global perspectives.</gtr:title><gtr:parentPublicationTitle>Survey of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fa9b360d10099bbc9e1acdd7798f4d8f"><gtr:id>fa9b360d10099bbc9e1acdd7798f4d8f</gtr:id><gtr:otherNames>Lane M</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0039-6257</gtr:issn><gtr:outcomeId>5aa6e12b7e3581.50886913</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>303ABA89-9387-490E-9282-95B19515752D</gtr:id><gtr:title>A Comprehensive Review of mTOR-Inhibiting Pharmacotherapy for the Treatment of Non-Infectious Uveitis.</gtr:title><gtr:parentPublicationTitle>Current pharmaceutical design</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/13c6009bf0609613d35766b24738795d"><gtr:id>13c6009bf0609613d35766b24738795d</gtr:id><gtr:otherNames>Blair J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>1381-6128</gtr:issn><gtr:outcomeId>58bee78b61d686.18084740</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>3E50974E-E8C6-497C-B2E0-A8B8B8B38933</gtr:id><gtr:title>Punctate inner choroidopathy: A review.</gtr:title><gtr:parentPublicationTitle>Survey of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/4fe177023d58ac2ae33635b89041b5e0"><gtr:id>4fe177023d58ac2ae33635b89041b5e0</gtr:id><gtr:otherNames>Ahnood D</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0039-6257</gtr:issn><gtr:outcomeId>58bee78b3b5f53.52878788</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>011BBA22-7E1A-4120-93B1-D804B6E7B1F9</gtr:id><gtr:title>&amp;quot;Black Holes&amp;quot; and the Ocular Glymphatic System: Author Response to &amp;quot;The Glymphatic System: A New Player in Ocular Diseases?&amp;quot;</gtr:title><gtr:parentPublicationTitle>Investigative ophthalmology &amp; visual science</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/47c2e1f6b35e40ba57613b609b4b0d3e"><gtr:id>47c2e1f6b35e40ba57613b609b4b0d3e</gtr:id><gtr:otherNames>Denniston AK</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2016-01-01</gtr:date><gtr:issn>0146-0404</gtr:issn><gtr:outcomeId>58bee7010abb06.93265416</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>8FFF07C3-39B3-4F95-8BA8-FD0F601C83EE</gtr:id><gtr:title>Characteristic optical coherence tomography findings in patients with primary vitreoretinal lymphoma: a novel aid to early diagnosis.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b2a80691aa2b2db91bd9bcd10441012e"><gtr:id>b2a80691aa2b2db91bd9bcd10441012e</gtr:id><gtr:otherNames>Barry RJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2018-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>5aa6e12b15e348.98692946</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1198AE1A-42AB-4C0C-AE34-149CE6C5F066</gtr:id><gtr:title>&amp;quot;The patient is speaking&amp;quot;: discovering the patient voice in ophthalmology.</gtr:title><gtr:parentPublicationTitle>The British journal of ophthalmology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/785ba76b09bce7acc76e8b3d8a44f123"><gtr:id>785ba76b09bce7acc76e8b3d8a44f123</gtr:id><gtr:otherNames>Dean S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2017-01-01</gtr:date><gtr:issn>0007-1161</gtr:issn><gtr:outcomeId>5aa6e12c5a9171.18557941</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0600416</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>A9061818-9B1E-495A-9617-7C77200827C2</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Eye</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>25</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity><gtr:researchActivity><gtr:id>1BF330A9-C7B5-49C5-B54B-CF4FAE6DF1D8</gtr:id><gtr:percentage>75</gtr:percentage><gtr:text>2.1  Biological and endogenous factors</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>